SLCO1A2 and multiple endocrine neoplasia: To further clarify the role of ECs in MEN progression, we clustered the ECs into four subpopulations: C0 MALAT1+ ECs, C1 SLCO1A2+ ECs, C2 PLVAP+ ECs, and C3 ACKR1+ ECs.